{"id":197946,"date":"2024-10-19T12:36:10","date_gmt":"2024-10-19T12:36:10","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-15674-2016\/"},"modified":"2024-10-25T05:09:28","modified_gmt":"2024-10-25T05:09:28","slug":"aami-15674-2016","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-15674-2016\/","title":{"rendered":"AAMI 15674 2016"},"content":{"rendered":"
Specifies requirements for sterile, single-use, extracorporeal hard-shell cardiotomy\/venous reservoir systems and soft venous reservoir bags intended for use as a blood reservoir during cardiopulmonary bypass (CPB) surgery.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/ISO 15674:2016; Cardiovascular implants and artificial organs\u2014Hard-shell cardiotomy\/venous reservoir systems (with\/without filter) and soft venous reservoir bags <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Objectives and uses of AAMI standards andrecommended practices <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Standard Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents page <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Background of AAMI adoption of ISO 15674:2016 <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 4 Requirements 4.1 Biological characteristics 4.1.1 Sterility and non-pyrogenicity 4.1.2 Biocompatibility <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 4.2 Physical characteristics 4.2.1 General 4.2.2 Blood volumes 4.2.3 Connectors 4.3 Performance characteristics 4.3.1 Blood cell damage 4.3.1.1 Plasma-free haemoglobin 4.3.1.2 Platelet reduction and white blood cell reduction 4.3.2 Air-handling capacity 4.3.3 Priming volume of the reservoirs in accordance with the manufacturer\u2019s quality control management system 4.3.4 Defoaming characteristics <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 4.3.5 Volume calibration 4.3.6 Filtration efficiency 4.3.7 Break-through volume 4.3.8 Dynamic priming volume 4.3.9 Minimum and maximum volumes 4.3.10 Shelf life 5 Tests and measurements to determine compliance with this document 5.1 General 5.2 Biological characteristics 5.2.1 Sterility and non-pyrogenicity <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 5.2.2 Biocompatibility 5.3 Physical characteristics 5.3.1 Blood pathway integrity for soft venous reservoir bags 5.3.2 Blood pathway integrity for sealed hard-shell reservoirs 5.3.3 Connectors 5.3.4 Blood cell damage 5.3.4.1 Test media 5.3.4.2 Procedure Table 1 \u2014 Conditions for in vitro testing of blood cell damage <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | Table 2 \u2014 Sampling schedule 5.3.5 Filtration efficiency 5.3.5.1 Test liquid 5.3.5.2 Procedure 5.3.6 Shelf life 6 Information supplied by the manufacturer 6.1 Information on the reservoir (labelling) <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 6.2 Information on the packaging 6.2.1 Information on the unit container 6.2.2 Information on the shipping container 6.3 Information in the accompanying documents <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 6.4 Information in the accompanying documents in a prominent form 7 Packaging <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | Annex A (normative) Factors to be considered in evaluating performance characteristics <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/ISO 15674:2016 – Cardiovascular implants and artificial organs – Hard-shell cardiotomy\/venous reservoir systems (with\/without filter) and soft venous reservoir bags<\/b><\/p>\n |